New episodes every Tuesday!
GET NEW EPISODES TO YOUR EMAIL
Latest Episode
Living in the Now, with John Doe
Adipiscing elit dapibus, vulpu tate in donec tempor ultricies venenatis erat, aliquam posuere urna habitant rutrum iaculis Euismod maecenas varius. tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam
Merck’s soft guidance overshadows quarterly beat to send stock down 6%
Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.
Trump has two strong options to defuse the U.S. debt time-bomb. He should use them.
AI-fueled productivity growth, combined with realistic and constructive immigration reform, would put the U.S. economy on more solid footing.
PepsiCo’s revenue misses amid ‘subdued’ trends and Quaker Oats recall fallout
PepsiCo’s stock falls after revenue misses expectations for a third-straight quarter, amid “subdued” performance trends in North America.
Oil prices fall after U.S. imposes tariffs on China, Beijing retaliates
Oil futures fell Tuesday morning, losing ground as the U.S. implemented an additional 10% tariff on China imports and Beijing retaliated with measures of its own.
Ferrari offers cautious guidance. The stock revs higher anyway.
Sports-car maker Ferrari reported a jump in fourth-quarter profit, buoyed by product mix even as shipments grew just 2%.
This contrarian stock-market indicator is about to flash red. What that means for investors.
Wall Street strategists are largely leaning positive on stocks, and that may mean it’s time to go the other way.
Estée Lauder’s stock falls as cosmetics company swings to Q2 loss
Post Content
‘I’ve been named sole heir’: My father, 92, is a Korean War veteran and stays out until dawn playing poker. What can I do?
“The family is mortgaged, likely for more than it is currently worth, to cover Dad’s back taxes and credit-card and gambling debts.”
Palantir bear Morgan Stanley upgrades rating but still doesn’t call AI firm a buy
Morgan Stanley has finally conceded that Palantir Technologies is not a stock to sell, but its analysts aren’t quite ready to call it a buy either.
Stay Tuned For Our Latest Episodes
Anean eu enim justo. Vestibulum aliquam hende rit molestie. Mauris malesuada nisi sit amet augue accumsan tincidunt. Maecenas tincidunt aliquam hende rit molestie. Mauris malesuada.
Start Listening Today!
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas varius tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam hendrerit
